Lindbrook Capital, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$22,126
+45.2%
247
+38.0%
0.00%0.0%
Q2 2023$15,240
+2.9%
1790.0%0.00%0.0%
Q1 2023$14,812
+41.6%
179
+34.6%
0.00%
+100.0%
Q4 2022$10,460
+248.7%
133
+195.6%
0.00%0.0%
Q3 2022$3,000
+200.0%
45
+125.0%
0.00%
Q2 2022$1,0000.0%20
+33.3%
0.00%
Q1 2022$1,000
-66.7%
15
-65.9%
0.00%
-100.0%
Q3 2021$3,000
+200.0%
44
+300.0%
0.00%
Q1 2021$1,0000.0%11
+83.3%
0.00%
Q2 2020$1,0000.0%60.0%0.00%
Q1 2020$1,00060.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders